Header Logo

Connection

Joshua Eloge to Depressive Disorder, Treatment-Resistant

Back to Details
This is a "connection" page, showing publications Joshua Eloge has written about Depressive Disorder, Treatment-Resistant.
Joshua Eloge
Connection Strength
0.212
Depressive Disorder, Treatment-Resistant
  1. Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series. J Clin Psychiatry. 2023 02 01; 84(2).
    View in: PubMed
    Score: 0.212
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.